Document ID: chunk:federal_register_of_legislation:F2019L01353:reg:9
Version: federal_register_of_legislation:F2019L01353
Segment Type: reg
Provision Reference: reg 9
Character Range: 3986–5890

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting microscopic polyangiitis or death from microscopic polyangiitis with the circumstances of a person's relevant service:
         (1)          inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being:
            (a)          produced;
            (b)          excavated;
            (c)          drilled, cut or ground; or
            (d)          used in construction, manufacturing, cleaning or blasting;
         for a cumulative period of at least 2 500 hours before the clinical onset of microscopic polyangiitis;
(2)          having silicosis at the time of the clinical onset of microscopic polyangiitis;
(3)          being treated with a drug from the specified list of drugs at the time of the clinical onset of microscopic polyangiitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
         (4)          inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being:
            (a)          produced;
            (b)          excavated;
            (c)          drilled, cut or ground; or
            (d)          used in construction, manufacturing, cleaning or blasting;
         for a cumulative period of at least 2 500 hours before the clinical worsening of microscopic polyangiitis;
(5)          having silicosis at the time of the clinical worsening of microscopic polyangiitis;
(6)          being treated with a drug from the specified list of drugs at the time of the clinical worsening of microscopic polyangiitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(7)          inability to obtain appropriate clinical management for microscopic polyangiitis.